SCHEMBL404564

SCHEMBL404564

Nc1ccc(Cl)c(NC(=O)c2ccc(F)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.59
SMN1; SMN2 Q16637 4/20 0.58
ALDH1A1 P00352 2/20 0.58
RAB9A P51151 2/20 0.58
NPC1 O15118 1/20 0.58
HPGD P15428 1/20 0.55
KCNMA1 Q12791 1/20 0.55
HSD17B10 Q99714 2/20 0.55
MAPK1 P28482 1/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 1/20 0.54
KDM4E B2RXH2 1/20 0.53
HDAC8 Q9BY41 3/20 0.52
HDAC6 Q9UBN7 3/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SSTR3 P32745 1/20 0.51
LMNA P02545 1/20 0.48
HDAC2 Q92769 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29948374 1.00 HDAC1 (0.59) HDAC1SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL24730187 0.88 HSD17B10 (0.55) HDAC1SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL15668210 0.88 HDAC1 (0.68) HDAC1SMN1; SMN2RAB9ANPC1HSD17B10
SCHEMBL403486 0.84 HDAC1 (0.66) HDAC1SMN1; SMN2RAB9ANPC1KCNMA1
SCHEMBL15668355 0.84 MAPT (0.65) HDAC1SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8218087 0.81 MEN1 (0.56) HDAC1SMN1; SMN2RAB9ANPC1KCNMA1
SCHEMBL866785 0.80 MAPT (0.78) HDAC1SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL30492552 0.80 MAPT (0.78) HDAC1SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL24791968 0.79 HDAC1 (0.60) HDAC1ALDH1A1KCNMA1MAPK1MEN1
SCHEMBL4905569 0.79 MAPT (0.76) HDAC1SMN1; SMN2ALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343681-A1 MOLECULES HAVING PESTICIDAL UTILITY AND INTERMEDIATES AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2024-10-17 US disclosed
EP-4313939-A1 MOLECULES HAVING PESTICIDAL UTILITY AND INTERMEDIATES AND PROCESSES RELATED THERETO Corteva Agriscience LLC (US) 2024-02-07 EP disclosed
CN-117098750-A Molecules having pesticidal utility, and intermediates and methods related thereto 科迪华农业科技有限责任公司 2023-11-21 CN disclosed
WO-2022204080-A1 MOLECULES HAVING PESTICIDAL UTILITY AND INTERMEDIATES AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2022-09-29 WO disclosed
WO-2022204080-A1 MOLECULES HAVING PESTICIDAL UTILITY AND INTERMEDIATES AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2022-09-29 WO disclosed
EP-1957461-B1 BISAMIDE INHIBITORS OF HEDGEHOG SIGNALING GENENTECH INC (US) 2016-11-02 EP disclosed
US-8101610-B2 Blocking signals; anticancer agents GENENTECH, INC. (US) 2012-01-24 US disclosed
US-20080269215-A1 Bisamide Inhibitors of Hedgehog Signaling GENENTECH INC. (US) 2008-10-30 US disclosed
EP-1957461-A1 BISAMIDE INHIBITORS OF HEDGEHOG SIGNALING Genentech, Inc. (US) 2008-08-20 EP disclosed
WO-2007059157-A1 BISAMIDE INHIBITORS OF HEDGEHOG SIGNALING GENENTECH, INC. (US) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343681-A1 MOLECULES HAVING PESTICIDAL UTILITY AND INTERMEDIATES AND PROCESSES RELATED THERETO ACHE, DDT, MLYCD HDAC1 2988/4885SMN1; SMN2 3720/4885ALDH1A1 326/4885
US-20080269215-A1 Bisamide Inhibitors of Hedgehog Signaling SHH, GLI1, SMO HDAC1 105/4885SMN1; SMN2 4415/4885ALDH1A1 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.